Our research shows that nonmedicated PWS have increased expression of DA and 5-HT receptors and transporters in PBMCs, while those taking risperidone exhibit a decrease in 5-HT2A and SERT mRNA levels. The gene discussed is SLC6A4; the disease is Prader-Willi syndrome.